• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    180.59 Up 4.55(2.58%) Mar 27, 4:00PM EDT
    |After Hours : 180.59 0.00 (0.00%) Mar 27, 4:31PM EDT
    Add to Portfolio
    Prev Close:176.04
    Open:175.62
    Bid:178.05 x 200
    Ask:190.02 x 300
    1y Target Est:213.35
    Beta:1.21
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:175.43 - 183.00
    52wk Range:136.37 - 203.30
    Volume:1,450,673
    Avg Vol (3m):1,282,240
    Market Cap:36.51B
    P/E (ttm):55.40
    EPS (ttm):3.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNUp 2.58%36.51B
    AMGNUp 1.27%123.38B
    BAXUp 0.78%37.19B

    Key Statistics

    Forward P/E (1 yr):24.67
    P/S (ttm):15.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :5.89
    Quarterly EPS Est (Mar-15) :1.32
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.21

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback